Neuroendocrine Carcinomas

• CLINICAL_TRIALS trial_result · 2022-08-02
  Clinical Trial Update: A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours [Phase 2]

  Phase 2 clinical trial evaluating the combination of 177Lu-DOTATATE and nivolumab in neuroendocrine tumours and neuroendocrine carcinomas.

• CLINICAL_TRIALS trial_result · 2021-04-20
  Clinical Trial Update: Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin [Phase 2]

  A Phase 2 trial evaluating cisplatinum and everolimus in metastatic or unresectable extrapulmonary neuroendocrine carcinomas.